Maglasang, Rex Harold R.

HRN: 21-36-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
CEFTRIAXONE 1G (VIAL)
04/13/2025
04/20/2025
IV
2G
OD
For Herniorrhaphy
Waiting Final Action 
04/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/13/2025
04/20/2025
IV
2g
Q8
For Herniorrhaphy
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: